FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

B & B Pharmaceuticals Estradiol Recall

Estradiol, USP (Non-Micronized) (Hemihydrate), packaged in: a) 500 grams (NDC 63275-990…

B & B Pharmaceuticals, Inc. · Englewood, CO

Risk level
Class II
Reported by FDA
Apr 22, 2020
Recall ID
D-1244-2020
Check your lot numberHow we source this data

Summary

B & B Pharmaceuticals recalled Estradiol starting Apr 14, 2020. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1244-2020 on Apr 22, 2020. Reason: cGMP deviations: Presence of foreign material (Teflon)introduced at the production level. Status: Terminated.

Why it was recalled

cGMP deviations: Presence of foreign material (Teflon)introduced at the production level.

Product description

Estradiol, USP (Non-Micronized) (Hemihydrate), packaged in: a) 500 grams (NDC 63275-9900-8), b) 100 grams (NDC 63275-9900-5), c) 25 grams (NDC 63275-9900-4), Distributed by B&B Pharmaceuticals, Inc. 800-499-3100

Lot numbers, UPCs & expiration codes

Lot #: 18K26-BB02-PR00553, Reassay 10/09/2023 Product # 700365, 700362 & 700363

Where it was sold

USA Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1244-2020
Classification
Class II
Status
Terminated
Recall initiated
Apr 14, 2020
FDA report date
Apr 22, 2020
Quantity
3,825 grams
Recall type
Voluntary: Firm initiated
Recalling firm
B & B Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-1244-2020, exactly as published.

Show all FDA fields
City
Englewood
State
CO
Status
Terminated
Country
United States
Event ID
85440
Address
8591 Prairie Trail Dr Ste C600
Code information
Lot #: 18K26-BB02-PR00553, Reassay 10/09/2023 Product # 700365, 700362 & 700363
Postal code
80112-7075
Report date
Apr 22, 2020
Product type
Drugs
Recall number
D-1244-2020
Classification
Class II
Recalling firm
B & B Pharmaceuticals, Inc.
Product quantity
3,825 grams
Termination date
Jul 24, 2020
Reason for recall
cGMP deviations: Presence of foreign material (Teflon)introduced at the production level.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Estradiol, USP (Non-Micronized) (Hemihydrate), packaged in: a) 500 grams (NDC 63275-9900-8), b) 100 grams (NDC 63275-9900-5), c) 25 grams (NDC 63275-9900-4), Distributed by B&B Pharmaceuticals, Inc. 800-499-3100
Distribution pattern
USA Nationwide
Recall initiation date
Apr 14, 2020
Initial firm notification
Letter
Center classification date
Apr 16, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1244-2020, published Apr 22, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls